{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T04:04:24Z","timestamp":1793765064626,"version":"4.6.1"},"reference-count":26,"publisher":"Society of Nuclear Medicine","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.2967\/jnumed.123.266390","type":"journal-article","created":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T11:10:30Z","timestamp":1704971430000},"page":"199-205","source":"Crossref","is-referenced-by-count":33,"title":["Initial Experience with\n                    <sup>68<\/sup>\n                    Ga-FAP-2286 PET Imaging in Patients with Urothelial Cancer"],"prefix":"10.2967","volume":"65","author":[{"given":"Vadim S.","family":"Koshkin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vipul","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brad","family":"Kline","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenique","family":"Escobar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya","family":"Aslam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew R.","family":"Cooperberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul R.","family":"Aggarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"de Kouchkovsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Chou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxwell V.","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terence","family":"Friedlander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sima","family":"Porten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas A.","family":"Hope","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2024,1,11]]},"reference":[{"key":"2024020105551734000_65.2.199.1","doi-asserted-by":"publisher","DOI":"10.1097\/ju.0000000000001633"},{"key":"2024020105551734000_65.2.199.2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21763"},{"key":"2024020105551734000_65.2.199.3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa022148"},{"key":"2024020105551734000_65.2.199.4","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(01)62067-6"},{"key":"2024020105551734000_65.2.199.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2008.10.026"},{"key":"2024020105551734000_65.2.199.6","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2541090361"},{"key":"2024020105551734000_65.2.199.7","doi-asserted-by":"crossref","first-page":"703","DOI":"10.3390\/diagnostics10090703","article-title":"The role of imaging in bladder cancer diagnosis and staging","volume":"10","author":"Galgano","year":"2020","journal-title":"Diagnostics (Basel)."},{"key":"2024020105551734000_65.2.199.8","doi-asserted-by":"crossref","first-page":"565086","DOI":"10.3389\/fonc.2020.565086","article-title":"The role of 18F-FDG PET\/CT in guiding precision medicine for invasive bladder carcinoma","volume":"10","author":"Girard","year":"2020","journal-title":"Front Oncol."},{"key":"2024020105551734000_65.2.199.9","doi-asserted-by":"crossref","first-page":"833.e9","DOI":"10.1016\/j.urolonc.2021.04.027","article-title":"The role of 18F-FDG PET\/CT scan compared to CT-scan alone for lymph node staging before radical cystectomy in patients with bladder cancer","volume":"39","author":"Moussa","year":"2021","journal-title":"Urol Oncol."},{"key":"2024020105551734000_65.2.199.10","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.121.262134"},{"key":"2024020105551734000_65.2.199.11","doi-asserted-by":"publisher","DOI":"10.1038\/nrc.2016.73"},{"key":"2024020105551734000_65.2.199.12","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-019-0238-1"},{"key":"2024020105551734000_65.2.199.13","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.119.227967"},{"key":"2024020105551734000_65.2.199.14","doi-asserted-by":"crossref","first-page":"5744","DOI":"10.3390\/cancers13225744","article-title":"Radioligands targeting fibroblast activation protein (FAP)","volume":"13","author":"Lindner","year":"2021","journal-title":"Cancers (Basel)."},{"key":"2024020105551734000_65.2.199.15","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.1007\/s00259-022-05842-5","article-title":"Preclinical evaluation of FAP-2286 for fibroblast activation protein targeted radionuclide imaging and therapy","volume":"49","author":"Zboralski","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2024020105551734000_65.2.199.16","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.122.264544"},{"key":"2024020105551734000_65.2.199.17","doi-asserted-by":"crossref","first-page":"CT251","DOI":"10.1158\/1538-7445.AM2022-CT251","article-title":"LuMIERE: a phase 1\/2 study investigating safety, pharmacokinetics, dosimetry, and preliminary antitumor activity of 177Lu-FAP-2286 in patients with advanced or metastatic solid tumors [abstract]","volume":"82","author":"McConathy","year":"2022","journal-title":"Cancer Res."},{"key":"2024020105551734000_65.2.199.18","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1080\/15321819.2022.2095208","article-title":"Fibroblast activation protein (FAP) expression in CK5\/6 expressed (basal subtype) & CK20 expressed (luminal subtype) urothelial bladder carcinoma: an immunohistochemical study","volume":"43","author":"Hemida","year":"2022","journal-title":"J Immunoassay Immunochem."},{"key":"2024020105551734000_65.2.199.19","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.1007\/s00259-022-05761-5","article-title":"Feasibility of [68Ga]Ga-FAPI-46 PET\/CT for detection of nodal and hematogenous spread in high-grade urothelial carcinoma","volume":"49","author":"Unterrainer","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2024020105551734000_65.2.199.20","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s11307-022-01715-3","article-title":"Head-to-head intra-individual comparison of [68Ga]-FAPI and [18F]-FDG PET\/CT in patients with bladder cancer","volume":"24","author":"Novruzov","year":"2022","journal-title":"Mol Imaging Biol."},{"key":"2024020105551734000_65.2.199.21","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.eururo.2023.01.016","article-title":"Disease-free survival analysis for patients with high-risk muscle-invasive urothelial carcinoma from the randomized CheckMate 274 trial by PD-L1 combined positive score and tumor cell score","volume":"83","author":"Galsky","year":"2023","journal-title":"Eur Urol."},{"key":"2024020105551734000_65.2.199.22","doi-asserted-by":"crossref","first-page":"523","DOI":"10.3390\/biomedicines10030523","article-title":"Imaging cancer-associated fibroblasts (CAFs) with FAPi PET","volume":"10","author":"Gilardi","year":"2022","journal-title":"Biomedicines."},{"key":"2024020105551734000_65.2.199.23","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.121.262821"},{"key":"2024020105551734000_65.2.199.24","doi-asserted-by":"crossref","first-page":"LBA602","DOI":"10.1200\/JCO.2023.41.6_suppl.LBA602","article-title":"Results from phase 3 study of 89Zr-DFO-girentuximab for PET\/CT imaging of clear cell renal cell carcinoma (ZIRCON) [abstract]","volume":"41","author":"Shuch","year":"2023","journal-title":"J Clin Oncol."},{"key":"2024020105551734000_65.2.199.25","doi-asserted-by":"crossref","first-page":"4346","DOI":"10.1158\/1078-0432.CCR-22-1432","article-title":"Safety and efficacy of 90Y-FAPI-46 radioligand therapy in patients with advanced sarcoma and other cancer entities","volume":"28","author":"Fendler","year":"2022","journal-title":"Clin Cancer Res."},{"key":"2024020105551734000_65.2.199.26","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.120.259192"}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.123.266390","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T08:58:13Z","timestamp":1706777893000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.123.266390"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,11]]},"references-count":26,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,2,1]]},"published-print":{"date-parts":[[2024,2]]}},"alternative-id":["10.2967\/jnumed.123.266390"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.123.266390","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,11]]}}}